70
Participants
Start Date
August 15, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Niyad (nafamostat mesylate)
Niyad (nafamostat mesylate) lyophilized
Placebo (0.9% NaCl)
0.9% NaCl
RECRUITING
Mount Sinai, New York
RECRUITING
Northwell Health, Great Neck
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
Medical University of South Carolina, Charleston
NOT_YET_RECRUITING
AdventHealth, Orlando
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
RECRUITING
Henry Ford Health, Detroit
RECRUITING
Baylor University Medical Center, Dallas
RECRUITING
University of New Mexico, Albuquerque
RECRUITING
University of California Los Angeles, Los Angeles
Talphera, Inc
INDUSTRY